Please provide your email address to receive an email when new articles are posted on . The FDA approved ibrexafungerp, an oral, non-azole antifungal drug, for reducing the number of recurrent ...

Thrush is one of the most common infections in the world. It's caused by the fungi Candida—specifically, the yeast Candida albicans. Although yeast infections are normally treated easily with ...

Credit: Scynexis. Brexafemme is an oral antifungal agent representing a novel therapeutic class of structurally-distinct glucan synthase inhibitors known as triterpenoids. The Food and Drug ...

Candidiasis, commonly referred to as a yeast infection, is a fungal infection caused by the overgrowth of Candida species of fungus, which naturally resides in various parts of our body, including the ...

Yeast infections are a common but often misunderstood condition that affects millions of individuals, particularly women. While they are typically associated with vaginal discomfort, yeast infections ...

While most people recover from fungal infections like candidiasis, it can pose a serious risk for immuno-compromised patients ...

Successful management of denture-associated candidiasis relies heavily on mechanical disinfection rather than pharmacologic ...

Recurrent thrush can be a real problem and very difficult to eradicate unless the right treatment is found. The first step is to be sure that it is thrush that you are dealing with, and to determine ...